Early Detection and Staging of Endobronchial Lung and Pleural Cancer, Airway Injury, and Prostate Cancer
This study has been designed to utilize already obtained biopsy specimens for investigation of the utility of a new, non-invasive optical diagnostic technique. The study will allow a careful correlation between the Optical coherence tomography findings and conventional histology.
Checked against the public recordLast updated Oct 20, 2022 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- University of California, Irvine
- Interventions being studied
- Device: diagnostic
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Adult 18 years and older * Having procedure of endobronchial, transbronchial, and / or pleural biopsy Exclusion Criteria: * Currently participating in any other investigational drug or device evaluation. * Currently taking drugs that are sensitive to light.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Pulmonary and Critical Care Medicine, UCI Medical CenterOrange, California
- Urology department, UCI Medical CenterOrange, California
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Oct 20, 2022. Always confirm current availability with the study team.